SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601485-23-000077
Filing Date
2023-11-09
Accepted
2023-11-09 16:41:20
Documents
19
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K angn-20231109.htm   iXBRL 8-K 24041
2 EX-99.1 a2023-11x09xxeltxxx3q23f.htm EX-99.1 19209
6 a2023-11x09xxeltxxx3q23f001.jpg GRAPHIC 259211
7 a2023-11x09xxeltxxx3q23f002.jpg GRAPHIC 246353
8 a2023-11x09xxeltxxx3q23f003.jpg GRAPHIC 145823
9 a2023-11x09xxeltxxx3q23f004.jpg GRAPHIC 142165
10 a2023-11x09xxeltxxx3q23f005.jpg GRAPHIC 309896
11 a2023-11x09xxeltxxx3q23f006.jpg GRAPHIC 231347
  Complete submission text file 0001601485-23-000077.txt   2022213

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20231109.xsd EX-101.SCH 1989
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20231109_lab.xml EX-101.LAB 25138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20231109_pre.xml EX-101.PRE 13130
13 EXTRACTED XBRL INSTANCE DOCUMENT angn-20231109_htm.xml XML 2816
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 231393301
SIC: 2834 Pharmaceutical Preparations